Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2006 by NHS Greater Glasgow Yorkhill Division.
Recruitment status was:  Recruiting
Information provided by:
NHS Greater Glasgow Yorkhill Division Identifier:
First received: October 19, 2006
Last updated: NA
Last verified: October 2006
History: No changes posted
To determine whether the selective application of a combined treatment regimen of silver nitrate cautery and 4 weeks of Naseptin cream is superior to naseptin treatment alone in the management of recurrent paediatric epistaxis.

Condition Intervention Phase
Procedure: Nasal Cautery
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double-Blind
Primary Purpose: Treatment
Official Title: A Prospective Randomised Controlled Trial of Management of Recurrent Nosebleeds in Children: Antiseptic Cream Alone v's Antiseptic Cream With Nasal Cautery

Further study details as provided by NHS Greater Glasgow Yorkhill Division:

Estimated Enrollment: 216
Study Start Date: October 2006

Ages Eligible for Study:   1 Year to 14 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Children aged 1 - 14
  • History of repeated epistaxis with at least 1 episode in the previous 4 weeks prior to attending the ENT clinic.
  • Presence of prominent vessels on the anterior nasal septum on the side that reportedly bleeds (or on at least one side if bleeding is reported to be bilateral)

Exclusion Criteria:

  • No prominent vessels on examination (these children will be randomised but will be prescribed Naseptin alone and followed up in the same way as the children in the trial, for completeness of data)
  • Known bleeding disorders.
  • Allergy to peanuts, neomycin or chlorhexidine
  • Other causes of nose bleeding eg tumour.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00390663

United Kingdom
Royal Hospital for Sick Children Recruiting
Glasgow, Strathclyde, United Kingdom, G3 8SJ
Contact: Haytham Kubba    0141 201 1000      
Sponsors and Collaborators
NHS Greater Glasgow Yorkhill Division
Principal Investigator: Haytham Kubba, MBBS(Hons) MPhil FRCS FRCSEd Royal Hospital for Sick Children
  More Information Identifier: NCT00390663     History of Changes
Other Study ID Numbers: 05/EN/03
Study First Received: October 19, 2006
Last Updated: October 19, 2006

Keywords provided by NHS Greater Glasgow Yorkhill Division:
Nose bleed

Additional relevant MeSH terms:
Nose Diseases
Respiratory Tract Diseases
Otorhinolaryngologic Diseases
Pathologic Processes processed this record on May 25, 2017